MetLife Investment Management, LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ

Position in LXRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$351,384

+$264,749 QoQ

Shares Held

146,410

+165.3% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 149 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. LXRX ranks #150 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$351,384	146,410	+165.3%	Shares	Defined	2026-08-14
2024-09-30	$86,635	55,182	0.0%	Shares	Defined	2024-11-13
2024-06-30	$92,705	55,182	+67.9%	Shares	Defined	2024-08-13
2024-03-31	$78,868	32,862	-23.3%	Shares	Defined	2024-05-14
2023-09-30	$46,689	42,834	0.0%	Shares	Defined	2024-05-09
2023-06-30	$98,089	42,834	0.0%	Shares	Defined	2024-04-29
2023-03-31	$104,086	42,834	+96.2%	Shares	Defined	2024-05-09
2022-12-31	$41,704	21,835	-45.5%	Shares	Defined	2024-05-10
2022-09-30	$96,134	40,056	+56.4%	Shares	Defined	2024-05-10
2021-12-31	$100,879	25,604	0.0%	Shares	Defined	2024-05-17
2021-09-30	$123,155	25,604	—	Shares	Defined	2024-05-17
No filing history on record for this holder in this stock.